The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.
Iesato, Asumi, Stephanie Li, Peter M Sadow, Mohammadreza Abbasian, Ara Nazarian, Jack Lawler, and Carmelo Nucera. 2023. “The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.”. Thyroid : Official Journal of the American Thyroid Association 33 (7): 835-48.